BULLISHWHALES
BullishWhales · Analysts · Analyst Profile

Michael Okunewitch

Maxim Group · Equity Research Analyst

Analyst rating accuracy & track record

Michael Okunewitch does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
HCWBHCW Biologics Inc
Buy$35.00May 2025−89.1%Miss
ANEBAnebulo Pharmaceuticals Inc
Buy$3.00May 2025−65.9%Hit
RADXRadiopharm Theranostics Limited American Depositary Shares
Buy$12.00May 2025−22.3%Hit
CMMBChemomab Therapeutics Ltd DRC
Buy$7.00Feb 2025−86.0%Miss
LCTXLineage Cell Therapeutics Inc
Buy$3.00Jan 2025+172.9%Miss
CTORCitius Oncology, Inc.
Buy$3.00Nov 2024+40.2%Hit
OCGNOcugen Inc
Buy$4.00Oct 2024+83.2%Miss
CMMBChemomab Therapeutics Ltd DRC
Buy$4.00May 2024+50.2%Miss
ANEBAnebulo Pharmaceuticals Inc
Buy$6.00Sep 2023−26.8%Miss
ALZNAlzamend Neuro Inc
Buy$1.50Apr 2023−95.4%Miss
KPRXKiora Pharmaceuticals Inc
Buy$12.00Feb 2023−99.6%Miss
MDWDMediwound Ltd
Buy$25.00Dec 2022−11.5%Miss
BRTXBioRestorative Therapies Inc
Buy$6.00Sep 2022−54.3%Hit
HCWBHCW Biologics Inc
Buy$4.00Mar 2022−41.1%Miss
Go to

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.

v1.0.30